Organization | Logistics University of CAPF

Logistics University of CAPF Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial

2015

NCT02352077

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Affiliated Hospital of Logistics University of CAPF | Affiliated Hospital of Logistics Universtiy of CAPF

Active Ingredients

Drugs in Phase 2 Trials (2)

autologous mesenchymal stem cell-derived neural progenitors (1 trial)

autologous mesenchymal stem cells (3 trials)

Drugs in Phase 1 Trials (2)

bone marrow derived mononuclear cells (1 trial)

collagen (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Brain Injuries (Phase 1)

Spinal Cord Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 4